CERVINO

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma (CERVINO)

Near Add Your Location

Vanderbilt-Ingram Cancer Center
Henry-Joyce Cancer Clinic
Nashville, TN
  • Accepting patients
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
MUSC Hollings Cancer Center
Medical University of South Carolina
Charleston, SC
  • Accepting patients
Oregon Health and Science University
OHSU Knight Cancer Institute
Portland, OR
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.